The life sciences industry is growing as medtech, biopharma, and investors all face an era of unprecedented innovation and potential. However, firms are also preparing as much as possible for unexpected business challenges and the likelihood of volatility. In an industry that must balance profitability with product efficacy, many life sciences firms are working with new efficiencies to bolster research. In this whitepaper from Wolters Kluwer, you will learn how centralized, unified, and coordinated resources can help organizations overcome fragmented processes and miscommunications, leading to enhanced problem-solving and collaboration, as well as improved outcomes.

At ACOG 2025, Elizabeth Mollard, PhD, discussed her research on Medicaid PPD screening and coverage policies on PPD diagnosis.

GLP-1 receptor agonists showed promise in lowering obesity-related cancer risks in adults with type 2 diabetes, particularly colorectal cancer.

PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.

The opioid-sparing IVIB pain management strategy in adults aged 60 and older was effective in the immediate post-surgical period and associated with limited AEs.